Member Info for eviking

I am right in saying that about 50% of current buybacks has been completed? If the last pole of buyback is completed below 60p that would be a good deal for sure.

Excellent work on the calculations thanks.

China are not dumb. The mention of rare earth sanctions will only benefit China with much higher price so win win for China.

What is the average price paid on all the buybacks until today?

Donald Trump. Fake news and how to make money on trumps trade war mental

Pegg up agin

Amp holding only 3.94% of motif bio shares.

Sounds like we have a good defence for sure.

It is a banker 50p cross fingers.

Well go for the most expensive meal on the menu and a bottle of champagne or two.

MrsNewchurch a blind date :-)) will he be paying with a Lloyds credit card. Lol

Chat board rules no live l2 posts.

Very astute.

Sorry how is the drivers speed to do with a new pm?

Well summerized. Antonio stop the buybacks buy back a 40p.

I do like to add that the team at motif bio was as taken back as most long term holders was here.

The FDA approval team must have read the data submitted and come to the conclusion that for approval more data is needed to clarify their area of concern. Various ideas has been posted here but to honest it is all a guess. I really hate not knowing things damit. Only days away we know for sure.

Someone confident 400.000 buy rock and roll.

Sounds promising seems approval will take a bit longer for safety reasons.

More than 900 drugs have been implicated in causing liver injury and it is the most common reason for a drug to be withdrawn from the market. Hepatotoxicity and drug-induced liver injury also account for a substantial number of compound failures, highlighting the need for toxicity prediction models (e.g. DTI), and drug screening assays, such as stem cell-derived hepatocyte-like cells, that are capable of detecting toxicity early in the drug development process Chemicals often cause subclinical injury to the liver, which manifests only as abnormal liver enzyme tests.

Drug-induced liver injury is responsible for 5% of all hospital admissions and 50% of all acute liver